We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » GSK Agrees to New Warnings, Safety Studies for Avandia
GSK Agrees to New Warnings, Safety Studies for Avandia
November 16, 2007
While GlaxoSmithKline’s (GSK) Type 2 diabetes treatment Avandia remains on the market, it now carries an updated boxed warning and will be the subject of a long-term safety study comparing it to other oral diabetes medications.